Viewing Study NCT03502668


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2025-12-27 @ 10:50 PM
Study NCT ID: NCT03502668
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2018-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
Sponsor: Taiho Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module